Sechenov School
Home › Pathophysiology › Principles of Therapy for Digestive Disorders

Principles of Therapy for Digestive Disorders

For medical students2 min readUpdated 2026-10-10

The management of gastrointestinal tract disorders is based on a comprehensive approach comprising four fundamental pillars. The primary clinical goal is not merely to alleviate symptoms, but to eliminate the underlying cause of the pathology, disrupt its pathogenic cascade, and support the body's natural recovery processes.

Etiotropic ApproachAims at the direct or indirect elimination of the underlying cause of the gastrointestinal disease.
Pathogenetic ApproachBlocks key mechanisms of disorder development across all stages of digestion.
Sanogenetic ApproachActivates local and systemic defense mechanisms, stimulating tissue regeneration.
Symptomatic ApproachRelieves the patient's condition using analgesics and anti-stress agents.

Etiotropic Principle: Eliminating the Cause

The fundamental goal of etiotropic treatment is the complete elimination, cessation, or at least reduction of the intensity and duration of factors that provoke structural and functional impairments in the digestive organs.

This principle can be implemented in two main ways:

  1. Directly: The clinician targets primary damaging agents. This includes the removal of aggressive agents (such as alcohol or coarse dietary elements) and the eradication of pathogenic microorganisms.
  2. Indirectly: Correction of functions in other body systems that influence the gastrointestinal tract. For instance, therapy may target circulatory disorders (cardiovascular system), endocrine dysfunctions, as well as liver and renal diseases.

Pathogenetic Principle: Breaking the Vicious Cycle

The aim of pathogenetic therapy is to interrupt the sequential links in the pathogenesis of a specific disease. The primary objective here is to block the key mechanisms that lead to the disruption of normal digestive system function.

Key targets of intervention include:

Sanogenetic Principle: Stimulating Defenses

While other approaches combat the disease itself, the sanogenetic principle focuses on supporting the organism, specifically by stimulating its natural protective mechanisms.

The essence of this approach involves specialized measures that activate both systemic and local mechanisms, including:

Symptomatic Therapy: Improving Quality of Life

Symptomatic treatment focuses on relieving the patient's current condition. Unlike the etiotropic approach, it does not directly target the root cause of the disease, yet it plays a critical role in patient management. The primary objective is to prevent or fully eliminate distressing symptoms that exacerbate well-being.

To implement this principle, the following drug groups are utilized:

Mnemonic

EPSS: Etiology (remove cause) — Pathogenesis (break the chain) — Sanogenesis (support defenses) — Symptomatology (relieve pain).

Frequently asked questions

Which specific agents promote the normalization of gastrointestinal motor function during symptomatic therapy?

For symptomatic therapy, agents that support the normalization of digestive organ functions are utilized. Drugs and classes with explicitly described effects on GI motility include:

  • Prokinetics: domperidone and trimebutine — used to normalize peristalsis and sphincter tone.
  • Antispasmodics: hymecromone — an agent with selective action on the smooth muscle of the gastrointestinal tract and biliary system.
  • Lactitol — an agent with a complex mechanism of action, combining motility normalization with effects on microbiota composition and function.
  • STW 5 (Iberogast) — a fixed herbal combination whose mechanism includes normalizing motility across various GI segments.
  • Combined herbal preparations based on artichoke leaf extract and other botanical components — possess prokinetic properties, among others.
What is the difference between direct and indirect etiotropic treatment in gastroenterology?

Direct treatment eliminates the damaging factor itself (such as bacteria or alcohol). Indirect treatment addresses other systems (circulation, endocrine glands, kidneys) whose failure secondarily impacts digestion.

Is symptomatic therapy sufficient as a standalone treatment?

No. It is aimed solely at relieving the patient's condition (e.g., pain relief) and does not directly affect the root cause of the disease; therefore, it must always be used in combination with other methods.

Which stages of digestion are targeted by pathogenetic therapy?

It covers all stages: correcting taste and appetite disorders, as well as digestive dysfunctions in the oral cavity, stomach, and intestines.

Go deeper

More topics in Pathophysiology

Irritable Bowel SyndromePrinciples of Endocrinopathy TherapyPathology of the Hemostatic System: Thrombocytopenias and ThrombocytopathiesUlcerative Colitis: Pathophysiology and Clinical PresentationThrombotic SyndromeArterial HyperemiaHemorrhagic SyndromeVenous HyperemiaIschemiaHaemoblastosis: Pathophysiology and ClassificationClassification of HemoblastosesLeukemoid ReactionsPathophysiology →